Clara Sciorati Selected Research

Clara Sciorati Research Topics

Disease

11	Inflammation (Inflammations) 02/2022 - 08/2005
9	Muscular Dystrophies (Muscular Dystrophy) 04/2014 - 12/2006
4	Myositis (Idiopathic Inflammatory Myopathies) 02/2022 - 01/2014
4	Disease Progression 08/2015 - 01/2007
4	Neoplasms (Cancer) 07/2010 - 06/2004
3	COVID-19 01/2022 - 10/2021
3	Fibrosis (Cirrhosis) 08/2015 - 09/2013
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2022 - 04/2021
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 09/2013 - 04/2012
2	Ischemia 11/2011 - 03/2006
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Hypoxia (Hypoxemia) 10/2021
1	Cognitive Dysfunction 04/2021
1	Venous Insufficiency 04/2021
1	Vasculitis (Vasculitides) 03/2021
1	Dermatomyositis (Dermatopolymyositis) 03/2021
1	Sarcopenia 11/2020
1	Atrophy 11/2020
1	Nervous System Diseases (Neurological Disorders) 12/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2018
1	Reperfusion Injury 07/2018
1	Experimental Nervous System Autoimmune Disease 01/2018
1	Immunoglobulin G4-Related Disease 01/2018
1	Fatigue 08/2015
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 08/2015
1	Necrosis 03/2015
1	Lupus Nephritis 01/2015
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2015
1	Nephritis 01/2015
1	Antisynthetase syndrome 01/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2011
1	Pain (Aches) 07/2010

Drug/Important Bio-Agent (IBA)

10	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2015 - 06/2004
4	Pharmaceutical PreparationsIBA 04/2021 - 07/2010
4	Sarcoglycans (beta Sarcoglycan)IBA 03/2015 - 01/2007
3	Ibuprofen (Motrin)FDA LinkGeneric 04/2012 - 07/2010
2	Calcium DobesilateIBA 08/2022 - 04/2021
2	AntigensIBA 02/2022 - 08/2005
2	C-Reactive ProteinIBA 01/2022 - 11/2021
2	CytokinesIBA 10/2021 - 11/2020
2	TRPC6 Cation ChannelIBA 12/2018 - 07/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 08/2005
2	Toll-Like Receptor 7IBA 01/2018 - 03/2015
2	DystrophinIBA 08/2015 - 03/2015
2	Nitric Oxide DonorsIBA 09/2013 - 04/2012
2	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 04/2012 - 07/2010
2	Caspase 9IBA 04/2009 - 06/2004
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2005 - 02/2003
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 02/2022
1	Chromogranin AIBA 01/2022
1	AdiponectinIBA 11/2021
1	LeptinIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021
1	lactate dehydrogenase C4IBA 10/2021
1	CreatinineIBA 10/2021
1	IronIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021
1	AdipokinesIBA 10/2021
1	AlarminsIBA 10/2021
1	Galactose (Galactopyranose)FDA LinkGeneric 04/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	Etanercept (Enbrel)FDA Link 11/2020
1	Ion Channels (Ion Channel)IBA 07/2018
1	Signaling Lymphocytic Activation Molecule FamilyIBA 01/2018
1	GlucocorticoidsIBA 01/2018
1	InterferonsIBA 01/2018
1	PerforinIBA 01/2018
1	Granzymes (Granzyme)IBA 01/2018
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2018
1	Naproxen (Naprosyn)FDA LinkGeneric 08/2015
1	naproxen-n-butyl nitrateIBA 08/2015
1	AntibodiesIBA 03/2015
1	Glycerol (Glycerine)FDA LinkGeneric 03/2015
1	CardiotoxinsIBA 03/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2015
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2015
1	Macrophage Colony-Stimulating FactorIBA 01/2015
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2014
1	Histidine-tRNA LigaseIBA 01/2014
1	Molsidomine (SIN 10)IBA 09/2013
1	SteroidsIBA 04/2012
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2011
1	4-(nitrooxy)butyl 2-(4-isobutylphenyl)propanoateIBA 09/2011
1	Therapeutic UsesIBA 09/2011
1	Peroxynitrous Acid (Peroxynitrite)IBA 07/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009
1	Type I Tumor Necrosis Factor ReceptorsIBA 04/2009
1	Caspase 3 (Caspase-3)IBA 04/2009
1	necdinIBA 04/2009

Therapy/Procedure

11	Therapeutics 03/2021 - 06/2004
1	Critical Care (Surgical Intensive Care) 11/2021
1	Subcutaneous Injections 11/2020
1	Aftercare (After-Treatment) 01/2018
1	Nephrectomy 11/2011
1	Investigational Therapies (Experimental Therapy) 07/2010